当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Suzanne Wedzicha
Acute exacerbations of chronic obstructive pulmonary complaint (AECOPD) are occurrences of symptom worsening which have significant adverse consequences for cases [1]. Exacerbations are largely miscellaneous events associated with increased airway and systemic inflammation and physiological changes. The frequence of exacerbations is associated with accelerated lung function decline, quality of life impairment and increased mortality. They're triggered generally by respiratory contagions and bacteria, which infect the lower airway and increase airway inflammation. A proportion of cases appear to be more susceptible to exacerbations, with poorer quality of life and more aggressive complaint progression than those who have occasional exacerbations. Exacerbations also contribute significantly to healthcare expenditure. Prevention and mitigation of exacerbations are thus crucial goals of COPD operation.